Brief: Nyrada Says Cholesterol-Lowering Drug Candidate Will Not Be Taken Forward
June 26 (Reuters) - Nyrada Inc NYR.AX :
* CHOLESTEROL-LOWERING DRUG CANDIDATE WILL NOT BE TAKEN
FORWARD
INTO PLANNED PHASE I/IIA CLINICAL TRIAL
Source text for Eikon: ID:nASX7XCFwg
Further company coverage: NYR.AX
((Reuters.Briefs@thomsonreuters.com;))